Source: Business Wire

Press Release: NantHealth : NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD-L1 Expression at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

CHICAGO--(BUSINESS WIRE)--NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks ecosystem of companies, will present findings on how targeting immune checkpoints and employing combinations has led to clinical benefit across a variety of tumor types during the tumor biology session at the American Soci

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Patrick Soon-Shiong's photo - Chairman & CEO of NantHealth

Chairman & CEO

Patrick Soon-Shiong

CEO Approval Rating

89/100

NantHealth is a cloud-based medical Information Technology platform that enables medical professionals to share and deliver healthcare information. Read more